TAKE liquidity ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

22.15×	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
4.54×	4.54×	1.48×	0.40×	0.89×
4.54×	4.54×	1.48×	0.39×	0.89×
0.3	0.3	3.4	0.8	10.7
18.5	18.5	7.6	−53.9	−10.7

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

TAKE₹11.06

TAKE Limited

· Pharma & Health

₹ CrorePeersVIMTALABS SUVENMcap ₹164 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Altman Z-Score (Other Equity as RE)	—	—	—	—	22.15
Current Ratio	0.89	0.40	1.48	4.54	4.54
Quick Ratio	0.89	0.39	1.48	4.54	4.54
Cash, Equiv & ST Investments	10.7	0.8	3.4	0.3	0.3
Working Capital	-10.7	-53.9	7.6	18.5	18.5

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.